Dr. Blondino has over 20 years of broad based drug development experience in parenteral, oral liquid, and inhalation products. He is currently the Director of Drug Development at Kaleo, Inc. in Richmond, Virginia. He has held industrial positions of increasing responsibility at NovaDel Pharma, Magellan Laboratories, Baker Norton Pharmaceuticals, and Hoechst Marion Roussel. In addition, he has held academic positions at Virginia Commonwealth University. He received his Ph.D. in Pharmaceutics in 1995 from Virginia Commonwealth University after receiving his B.S. in Pharmacy from the same institution. He has published numerous articles and is co-inventor of 15 United States patents. My professional interests are in fulfilling unmet medical needs during life-threatening emergency situations, difficult to formulate compounds, drug delivery, and technology transfer.
Drug Delivery and Technology transfer